Phillips Electronics North America Corp. has recalled 71 HeartStart MRx defibrillators produced in September and October 2016 due to a defect that may cause the device to fail, the Food and Drug Administration announced Friday. If used in automated external defibrillator mode after failing, the device will not delivery patient therapy, which may lead to serious patient injury or death, the agency said. For more information and a list of affected devices, see the FDA notice.

Related News Articles

Perspective
There will always be administrative costs associated with operating a hospital. But the lion’s share of a hospital’s resources should be devoted to doing what…
Chairperson's File
September 17 is World Patient Safety Day. It’s an opportunity to spotlight the importance of ensuring all patients receive safe, quality care in all health…
Perspective
America’s hospitals and health systems have always aimed to provide the highest quality and safe care to patients, while helping every individual achieve their…
Headline
The AHA Sept. 12 released a new report that found hospital and health system performance on key patient safety and quality measures was better in the first…
Headline
Leaders of the AHA this week are participating in the International Hospital Federation's 47th annual World Hospital Congress in Rio de Janeiro, leading a…
Headline
In the latest "Safety Speaks" conversation, Christi Barney, R.N., vice president of quality and patient safety at Emerson Health, discusses the health system’s…